[1]朱俊靖, 陈汝家, 张勇, 等. 斑马鱼模型在药物毒性与安全性评价中的应用[C]// 华东地区第十二届实验动物科学学术交流会.宁波,2012.
[2]HE J H, GAO J M, HUANG C J, et al. Zebrafish models for assessing developmental and reproductive toxicity[J]. Neurotoxicology and Teratology, 2014, 42: 35-42.
[3]PARNG C. In vivo zebrafish assays for toxicity testing[J]. Current Opinion in Drug Discovery & Development, 2005, 8(1): 100-106.
[4]LEE E H, OH J H, PARK H J, et al. Simultaneous gene expression signature of heart and peripheral blood mononuclear cells in astemizoletreated rats[J]. Archives of Toxicology, 2010, 84(8): 609-618.
[5]王君, 胡霞敏, 曾繁典, 等. 阿司咪唑上市后心脏毒性安全性评价文献调研[J]. 药物流行病学杂志, 2009, 18(2): 85-87.
[6]郑卫红, 明章银, 胡本容, 等. 阿司咪唑对大鼠离体心脏心电图的影响[J]. 中国临床药理学与治疗学, 2007, 12(6): 682-685.
[7]李亚静, 王保玉. 白藜芦醇的研究进展[J]. 云南化工,2010,37(5): 70-74.
[8]熊小春, 安春妹. 白藜芦醇抗肿瘤的研究进展[J]. 黑龙江医药,2010,23(1):59-61.
[9]DAS S, CORDIS G A, MAULIK N, et al. Pharmacological preconditioning with resveratrol: Role of CREBdependent Bcl2 signaling via adenosine A3 receptor activation[J]. American Journal of PhysiologyHeart and Circulatory Physiology, 2005, 288(1): H328-H335.
[10]HATTORI R, OTANI H, MAULIK N, et al. Pharmacological preconditioning with resveratrol:Role of nitric oxide[J]. American Journal of PhysiologyHeart and Circulatory Physiology, 2002, 282(6): H1988-H1995.
[11]孙桂金, 潘杰, 刘可春, 等. 苯硫脲对斑马鱼黑色素生成及早期发育的影响[J]. 水产科学, 2011, 30(7): 387-390.
[12]吴晓敏, 何秋霞, 韩利文, 等. 阿司咪唑对斑马鱼心脏毒性的初步研究[J]. 中国药理学通报, 2013, 29(9): 1251-1254.
[13]MITTELSTADT S W, HEMENWAY C L, CRAIG M P, et al. Evaluation of zebrafish embryos as a model for assessing inhibition of hERG[J]. Journal of Pharmacological and Toxicological Methods, 2008, 57(2): 100-105. |